» Articles » PMID: 29623644

Intranasal Instillation of Iron Oxide Nanoparticles Induces Inflammation and Perturbation of Trace Elements and Neurotransmitters, but Not Behavioral Impairment in Rats

Overview
Publisher Springer
Date 2018 Apr 7
PMID 29623644
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last decades, engineered nanomaterials have been widely used in various applications due to their interesting properties. Among them, iron oxide nanoparticles (IONPs) are used as theranostic agents for cancer, and also as contrast agents in magnetic resonance imaging. With the increasing production and use of these IONPs, there is an evident raise of IONP exposure and subsequently a higher risk of adverse outcome for humans and the environment. In this work, we aimed to investigate the effects of sub-acute IONP exposure on Wistar rat, particularly (i) on the emotional and learning/memory behavior, (ii) on the hematological and biochemical parameters, (iii) on the neurotransmitter content, and (vi) on the trace element homeostasis. Rats were treated during seven consecutive days by intranasal instillations at a dose of 10 mg/kg body weight. The mean body weight increased significantly in IONP-exposed rats. Moreover, several hematological parameters were normal in treated rats except the platelet count which was increased. The biochemical study revealed that phosphatase alkaline level decreased in IONP-exposed rats, but no changes were observed for the other hepatic enzymes (ALT and AST) levels. The trace element homeostasis was slightly modulated by IONP exposure. Sub-acute intranasal exposure to IONPs increased dopamine and norepinephrine levels in rat brain; however, it did not affect the emotional behavior, the anxiety index, and the learning/memory capacities of rats.

Citing Articles

Comprehensive Analysis of the Potential Toxicity of Magnetic Iron Oxide Nanoparticles for Medical Applications: Cellular Mechanisms and Systemic Effects.

Nowak-Jary J, Machnicka B Int J Mol Sci. 2024; 25(22).

PMID: 39596080 PMC: 11594039. DOI: 10.3390/ijms252212013.


Local Administrations of Iron Oxide Nanoparticles in the Prefrontal Cortex and Caudate Putamen of Rats Do Not Compromise Working Memory and Motor Activity.

Irrsack E, Aydin S, Bleckmann K, Schuller J, Dringen R, Koch M Neurotox Res. 2023; 42(1):6.

PMID: 38133743 PMC: 10746586. DOI: 10.1007/s12640-023-00684-x.


Neonatal exposure to ultrafine iron but not combined iron and sulfur aerosols recapitulates air pollution-induced impulsivity in mice.

Eckard M, Marvin E, Conrad K, Oberdorster G, Sobolewski M, Cory-Slechta D Neurotoxicology. 2022; 94:191-205.

PMID: 36509212 PMC: 9839645. DOI: 10.1016/j.neuro.2022.12.004.


Differences in Distribution and Biological Effects of FO@PEG Nanoparticles in Normotensive and Hypertensive Rats-Focus on Vascular Function and Liver.

Micurova A, Kluknavsky M, Liskova S, Balis P, Skratek M, Okruhlicova L Biomedicines. 2021; 9(12).

PMID: 34944671 PMC: 8698428. DOI: 10.3390/biomedicines9121855.


Developmental Neurotoxicity Screening for Nanoparticles Using Neuron-Like Cells of Human Umbilical Cord Mesenchymal Stem Cells: Example with Magnetite Nanoparticles.

Coccini T, Pignatti P, Spinillo A, De Simone U Nanomaterials (Basel). 2020; 10(8).

PMID: 32824247 PMC: 7466682. DOI: 10.3390/nano10081607.


References
1.
von Hundelshausen P, Weber C . Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res. 2007; 100(1):27-40. DOI: 10.1161/01.RES.0000252802.25497.b7. View

2.
Hasan D, Amans M, Tihan T, Hess C, Guo Y, Cha S . Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation. Transl Stroke Res. 2012; 3(Suppl 1):166-73. PMC: 3445332. DOI: 10.1007/s12975-012-0172-y. View

3.
Yarjanli Z, Ghaedi K, Esmaeili A, Rahgozar S, Zarrabi A . Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci. 2017; 18(1):51. PMC: 5485499. DOI: 10.1186/s12868-017-0369-9. View

4.
Kim Y, Kong S, Chen L, Pisanic 2nd T, Jin S, Shubayev V . In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms. Nanomedicine. 2013; 9(7):1057-66. PMC: 3783535. DOI: 10.1016/j.nano.2013.05.002. View

5.
Kim E, Kim J, Kim L, Choi S, Park I, Han J . The effect of neutral-surface iron oxide nanoparticles on cellular uptake and signaling pathways. Int J Nanomedicine. 2016; 11:4595-4607. PMC: 5028088. DOI: 10.2147/IJN.S110332. View